"Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture"

Cecilia Menna, Elena De Falco, Luca Pacini, Gaia Scafetta, Paola Ruggieri, Rosa Puca, Vincenzo Petrozza, Anna Maria Ciccone, Erino Angelo Rendina, Antonella Calogero, Mohsen Ibrahim

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Fetal lung adenocarcinoma (FLAC) is a rare variant of lung adenocarcinoma. Studies regarding FLAC have been based only on histopathological observations, thus representative in vitro models of FLAC cultures are unavailable. We have established and characterized a human primary FLAC cell culture, exploring its biology, chemosensitivity, and migration. FLAC cells and specimen showed significant upregulation of VEGF165 and HIF-1α mRNA levels. This observation was confirmed by in vitro chemosensitivity and migration assay, showing that only Axitinib was comparable to Cisplatin treatment. We provide a suitable in vitro model to further investigate the nature of this rare type of cancer.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalCancer Investigation
Volume32
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Antineoplastic drugs
  • Axitinib
  • Cancer primary cell cultures
  • Fetal lung adenocarcinoma
  • Lung adenocarcinoma
  • Vascular endothelial growth factor

Fingerprint

Dive into the research topics of '"Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture"'. Together they form a unique fingerprint.

Cite this